Cargando…

Intelectin-1 is a novel prognostic biomarker for hepatocellular carcinoma

The molecular mechanisms of hepatocellular carcinoma (HCC) are still not well understood. Gene microarray analysis showed that the expression of Intelectin-1 (ITLN-1) in tumor-adjacent normal liver tissue was 454.8 times higher than in the corresponding cancer tissue. ITLN-1 is a secreted soluble gl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jiang, Tao, Hai-Su, Yuan, Tong, Huang, Zhi-Yong, Zhang, Er-Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695524/ http://dx.doi.org/10.1097/MD.0000000000036474

Ejemplares similares

Exploring novel independent prognostic biomarkers for hepatocellular carcinoma based on TCGA and GEO databases
por: Hou, Miaomiao
Publicado: (2022)

Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resection
por: Jing, Chu-Yu, et al.
Publicado: (2017)

High expression of HILPDA is an adverse prognostic prognostic factor in hepatocellular carcinoma
por: Wang, Xiao, et al.
Publicado: (2023)

Prognostic role of urokinase plasminogen activator in hepatocellular carcinoma: A protocol for systematic review and meta analysis
por: Tao, Pengxian, et al.
Publicado: (2020)

Prognostic significance of glypican-3 expression in hepatocellular carcinoma: A meta-analysis
por: Liu, Hong, et al.
Publicado: (2018)

Prognostic value and potential molecular mechanism of ITGB superfamily members in hepatocellular carcinoma
por: Xie, Haixiang, et al.
Publicado: (2023)

Elevated Preoperative Serum Hs-CRP Level as a Prognostic Factor in Patients Who Underwent Resection for Hepatocellular Carcinoma
por: Liu, Yu-Bin, et al.
Publicado: (2015)

Screening of significant biomarkers with poor prognosis in hepatocellular carcinoma via bioinformatics analysis
por: Sun, Quanquan, et al.
Publicado: (2020)

Serum SALL4 as a predictive biomarker for the prognosis of patients with hepatocellular carcinoma who underwent nonsurgical treatment
por: Chen, Zhixian, et al.
Publicado: (2022)

Bioinformatics analysis and experimental verification of five metabolism-related lncRNAs as prognostic models for hepatocellular carcinoma
por: Wang, Wei, et al.
Publicado: (2022)

Prognostic value of sarcopenic visceral obesity in hepatocellular carcinoma treated with TACE
por: Li, Yuxuan, et al.
Publicado: (2023)

Chemoembolization for hepatocellular carcinoma fed by right internal thoracic artery
por: Shen, Tao, et al.
Publicado: (2017)

CCT6A, a novel prognostic biomarker for Ewing sarcoma
por: Jiang, Jie, et al.
Publicado: (2021)

LncRNA DIRC1 is a novel prognostic biomarker and correlated with immune infiltrates in stomach adenocarcinoma
por: Lin, Yuning, et al.
Publicado: (2022)

Prognostic related gene index for predicting survival and immunotherapeutic effect of hepatocellular carcinoma
por: Du, Zhongxiang, et al.
Publicado: (2023)

Co-expression of KIAA1199 and hypoxia-inducible factor 1α is a biomarker for an unfavorable prognosis in hepatocellular carcinoma
por: Wang, Dan, et al.
Publicado: (2020)

Prognostic significance of sarcopenia in patients with hepatocellular carcinoma treated with lenvatinib: A retrospective analysis
por: Dong, Dong, et al.
Publicado: (2022)

STAT2 act a prognostic biomarker and associated with immune infiltration in kidney renal clear cell carcinoma
por: Zeng, Tao, et al.
Publicado: (2023)

PDPN is a prognostic biomarker and correlated with immune infiltrating in gastric cancer
por: Hu, Liya, et al.
Publicado: (2020)

TREM1 as a novel prognostic biomarker and tumor immune microenvironment evaluator in glioma
por: Lu, Qin, et al.
Publicado: (2023)

IKZF3 is a novel prognostic biomarker for head and neck squamous cell carcinoma: A study based on bioinformatics analysis
por: Li, Hongxiang, et al.
Publicado: (2023)

Prognostic value of immunoscore to identify mortality outcomes in adults with HBV-related primary hepatocellular carcinoma
por: Yao, Qinwei, et al.
Publicado: (2017)

Methylation of the ataxia telangiectasia mutated gene (ATM) promoter as a radiotherapy outcome biomarker in patients with hepatocellular carcinoma
por: Yan, Xinjian, et al.
Publicado: (2020)

Novel oxidative stress-related prognostic biomarkers for melanoma associated with tumor metastasis
por: Wu, Xianpei, et al.
Publicado: (2021)

A 3-DNA methylation signature as a novel prognostic biomarker in patients with sarcoma by bioinformatics analysis
por: Wang, Xiao-Wei, et al.
Publicado: (2021)

Successful management of the hepatocellular carcinoma with inferior vena cava tumor thrombus: A case report
por: Liu, Yuanjun, et al.
Publicado: (2021)

Statin-Based Palliative Therapy for Hepatocellular Carcinoma
por: Shao, Joni Yu-Hsuan, et al.
Publicado: (2015)

Identification of TLRs as potential prognostic biomarkers for lung adenocarcinoma
por: Ying, Junjie, et al.
Publicado: (2023)

LncRNA ALMS1-IT1 is a novel prognostic biomarker and correlated with immune infiltrates in colon adenocarcinoma
por: Lin, Yuning, et al.
Publicado: (2022)

The Epidemiological Investigation on the Risk Factors of Hepatocellular Carcinoma: A Case–Control Study in Southeast China
por: Niu, Jianjun, et al.
Publicado: (2016)

Study on the gene signature related to immune microenvironment on viral and nonviral infections of hepatocellular carcinoma
por: Qian, Hong, et al.
Publicado: (2021)

Circulating uPA as a potential prognostic biomarker for resectable esophageal squamous cell carcinoma
por: He, Xiao, et al.
Publicado: (2019)

Identification of potential biomarkers of peripheral blood mononuclear cell in hepatocellular carcinoma using bioinformatic analysis: A protocol for systematic review and meta-analysis
por: Peng, Jin-lin, et al.
Publicado: (2021)

Identification of an immune-related 6-lncRNA panel with a good performance for prognostic prediction in hepatocellular carcinoma by integrated bioinformatics analysis
por: Lu, Shan, et al.
Publicado: (2023)

Development and validation of a robust immune-related risk signature for hepatocellular carcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

The clinicopathological features and prognostic factors of gastric squamous cell carcinoma
por: Dong, Caixia, et al.
Publicado: (2016)

Serum microRNA panel for early diagnosis of the onset of hepatocellular carcinoma
por: Zhang, Ying, et al.
Publicado: (2017)

Pan-cancer analysis of aldolase B gene as a novel prognostic biomarker for human cancers
por: Zhao, Nannan, et al.
Publicado: (2023)

Identification of novel biomarkers and small-molecule compounds for nasopharyngeal carcinoma with metastasis
por: Mi, Jing-Lin, et al.
Publicado: (2020)

Efficacy and Safety of Intensity-Modulated Radiotherapy Following Transarterial Chemoembolization in Patients With Unresectable Hepatocellular Carcinoma
por: Zhang, Tao, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_q12h33u8jc4vp21mptcloqlv2s